The Role of HMGB-1 in Chronic Stroke

Terminated

Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery. Trial Stopped: study stopped because patient access became extremely limited for the initial data entry point.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 March 2018.

1 Sep 2012 9 Oct 2012 1 Dec 2017 1 Feb 2018 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts